BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-37@pharmaconomics
DTSTAMP:20260707T021628Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:AUGX Phase 3 — AVTX-803 (L-Fucose)
DESCRIPTION:Phase 3 trial results for AVTX-803 (L-Fucose) in Leukocyte Adhesion Deficiency are due Nov 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT05462587\n\nTrack it: https://pharmaconomics.com/e/37
URL:https://pharmaconomics.com/e/37
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AUGX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR